CTMX — CytomX Therapeutics Share News
0.000.00%
Last trade - 00:00- $531.67m
- $201.39m
- $76.20m
CytomX Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Cytomx Therapeutics Says On Aug 22, Entered Into Transition Agreement With Abbvie Global Enterprises Ltd.
Brief: Cytomx Therapeutics Inc Files For Offering Of Up To 25.96 Million Shares Common Stock By Selling Securityholders - SEC Filing
CytomX Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: CytomX Therapeutics posts Q2 EPS USD -0.02
CytomX Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
CytomX Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: CytomX Therapeutics Announces $30 Million Private Placement From Bvf Partners L.P.
Brief: Cytomx Therapeutics Reports First Quarter 2023 Financial Results And Provides Business Update
CytomX Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview
CytomX Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Energy firms, nickel stocks, gold miners
U.S. STOCKS ON THE MOVE-Oscar Health, Walgreens Boots, Alibaba Group
U.S. STOCKS ON THE MOVE-Oscar Health, Ciena, Lovesac
U.S. STOCKS ON THE MOVE-Walgreens Boots, Fusion Fuel, PVH Corp
CytomX falls as Abbvie terminates collaboration deal, loss widens
CytomX Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
CytomX Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Cytomx Therapeutics Inc Does Not Consider Its Exposure To Any Liquidity Concern At SVB To Be Significant